Other authors

[Galván-Casas C] Servicio de Dermatología, Hospital Universitario de Móstoles, Móstoles, Madrid, Spain. [Català A] Servicio de Dermatología, Sede Plató, Hospital Clínic, Barcelona, Spain. [Muñoz-Santos C] Servicio de Dermatología, Hospital General de Granollers, Granollers, Spain

Hospital General de Granollers

Publication date

2022-03-18T08:56:47Z

2022-03-18T08:56:47Z

2021-10-01



Abstract

Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Skin reactions; Vacines


Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Reacciones cutáneas; Vacunas


Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Reaccions cutànies; Vacunes


Vaccines against the severe acute respiratory coronavirus 2, which are the first to be used in humans against any coronavirus, were developed and produced in record time. Dermatologic adverse effects appeared during clinical trials and have also been described in the population since approval. Just as descriptions and categorization of skin manifestations of the coronavirus disease 2019 proved important for understanding the disease itself, characterizing the effects of vaccines may also further that goal. This paper reviews the properties of the different types of vaccines currently available and under development and describes how they interact with the immune system and the clinical signs they may cause. We focus on dermatologic adverse effects reported to date and recommendations for managing them.

Document Type

Article


Published version

Language

English

Publisher

Elsevier España

Related items

Actas dermo-sifiliográficas;112(9)

https://doi.org/10.1016/j.adengl.2021.07.028

Recommended citation

This citation was generated automatically.

Rights

Attribution-NonCommercial-NoDerivatives 4.0 International

http://creativecommons.org/licenses/by-nc-nd/4.0/

This item appears in the following Collection(s)